LY3884965

N/A

Report date: 2024/07/31 11:36:39

Base Information

Drug NameLY3884965
Drug Alias NameLY3884965LY-3884965PR009PR-009
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionTriggering receptor expressed on myeloid cells 2 stimulants
TargetsTriggering receptor expressed on myeloid cells 2
Therapy Area/IndicationsLeukoencephalopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrevail Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrevail Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukoencephalopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A